|
US7223739B1
(en)
|
1995-06-07 |
2007-05-29 |
Powderject Vaccines, Inc. |
Adjuvanted genetic vaccines
|
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
|
US6884435B1
(en)
|
1997-01-30 |
2005-04-26 |
Chiron Corporation |
Microparticles with adsorbent surfaces, methods of making same, and uses thereof
|
|
ATE235890T1
(de)
|
1997-01-30 |
2003-04-15 |
Chiron Corp |
Verwendung von mikropartikeln mit adsorbiertem antigen zur stimulierung der immunabwehr
|
|
NZ510928A
(en)
|
1998-10-01 |
2002-10-25 |
Powderject Res Ltd |
Spray coated powder composition formed from seed particles between 10-100 micrometres coated with an aqueous pharmaceutical composition
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
PT1146861E
(pt)
|
1999-02-03 |
2005-10-31 |
Powderject Res Ltd |
Formulacoes de particulas de hidrogel
|
|
AU3593200A
(en)
|
1999-02-09 |
2000-08-29 |
Powderject Vaccines, Inc. |
(mycobacterium tuberculosis), immunization
|
|
US6565528B1
(en)
|
1999-05-07 |
2003-05-20 |
Scimed Life Systems, Inc. |
Apparatus and method for delivering therapeutic and diagnostic agents
|
|
US7147633B2
(en)
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
JP2004509914A
(ja)
|
2000-09-28 |
2004-04-02 |
カイロン コーポレイション |
微粒子組成物およびその製造方法
|
|
EP1372708B1
(en)
|
2001-02-13 |
2008-06-18 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY |
Vaccine for transcutaneous immunization against travellers' diarrhoea
|
|
GB0103620D0
(en)
*
|
2001-02-14 |
2001-03-28 |
Prometic Biosciences Ltd |
Sterile composition and its preparation
|
|
PT1631264E
(pt)
|
2003-06-02 |
2009-11-03 |
Novartis Vaccines & Diagnostic |
Composições imunogénicas à base de micropartículas biodegradáveis que compreendem um toxóide de difteria e do tétano
|
|
EP1671655A4
(en)
*
|
2003-08-29 |
2009-08-12 |
Anges Mg Inc |
GENE THERAPY FOR SKIN DISEASE USING NEEDLE-FREE SYRINGE
|
|
US9017697B2
(en)
|
2006-10-12 |
2015-04-28 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
DE102007004855B4
(de)
*
|
2007-01-31 |
2014-03-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vorrichtung und Verfahren zur Deposition von biologischem Material in einem Zielsubstrat
|
|
EP2612868B1
(en)
|
2007-11-01 |
2018-08-15 |
Astellas Pharma Inc. |
Immunosuppressive polypeptides and nucleic acids
|
|
CA2816529A1
(en)
|
2010-11-01 |
2012-05-10 |
University Of Technology, Sydney |
Immune-modulating agents and uses therefor
|
|
JP2025523481A
(ja)
|
2022-07-01 |
2025-07-23 |
レセンスメディカル、インコーポレイテッド |
組成物が冷媒とともにスプレーされることになるモジュール
|